As we observed a relation between the expression of EGFR and those of FAM83A and B, we further investigated whether they might be affected by EGFR-targeted TKI treatment in NSCLC cell lines (Figure 5). This evidence concerns the gene EGFR and non-small cell lung carcinoma.